brentwood semaglutide weight loss Peptides Franklin TN | Consult First brentwood semaglutide weight loss Semaglutide

GLP-1 Receptor Agonists

In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease

Accessibility and Convenience: Evaluate how easy it is to schedule consultations, access prescriptions, and communicate with medical professionals

"Public Health"

Will managing side effects help improve treatment results

The medication carries a black box warning about thyroid C-cell tumors, but no human cases have been definitively linked to GLP-1 agonist use